Testosterone induces apoptosis in cardiomyocytes by increasing proapoptotic signaling involving tumor necrosis factor-α and renin angiotensin system

Human and Experimental Toxicology

Volumn 34, Issue 11, 2015, Pages 1139-1147

  Do Nascimento, A M ^a   De Lima, E M ^a   Boechat G A P ^a   Meyrelles, S D S ^b   Bissoli, N S ^b   Lenz, D ^a   Endringer, D C ^a   De Andrade, T U ^a  

^a UNIVERSIDADE VILA VELHA   (Brazil)

^b FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

Author keywords

ACE; Anabolic agents; apoptosis; caspase 3; H9c2; TNF

Indexed keywords

ANGIOTENSIN II; CASPASE 3; DIPEPTIDYL CARBOXYPEPTIDASE; DOXORUBICIN; ETANERCEPT; LOSARTAN; TESTOSTERONE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; EMBRYO; ENZYME ACTIVATION; ENZYME ACTIVITY; FLOW CYTOMETRY; GROWTH INHIBITION; HEART MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIGNAL TRANSDUCTION; ANIMAL; CARDIAC MUSCLE CELL; CELL LINE; DRUG EFFECTS; METABOLISM;

ANIMALS; APOPTOSIS; CASPASE 3; CELL LINE; MYOCYTES, CARDIAC; PEPTIDYL-DIPEPTIDASE A; RATS; RENIN-ANGIOTENSIN SYSTEM; SIGNAL TRANSDUCTION; TESTOSTERONE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84944029450     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327115571766     Document Type: Article

References (45)

1. Sullivan ML, Martinez CM, Gennis P, et al. The cardiac toxicity of anabolic steroids. Prog Cardiovasc Dis 1998; 41: 1-15.
2. Nascimento JH, Medei E,. Cardiac effects of anabolic steroids: hypertrophy, ischemia and electrical remodelling as potential triggers of sudden death. Mini Rev Med Chem 2011; 11: 425-429.
3. Montisci M, El Mazloum R, Cecchetto G, et al. Anabolic androgenic steroids abuse and cardiac death in athletes: morphological and toxicological findings in four fatal cases. Forensic Sci Int 2012; 217 (1-3): 13-18.
4. Behrendt H, Bofin H,. Myocardial cell lesions caused by an anabolic hormone. Cell Tissue Res 1977; 181: 423-426.
5. Kindermann W,. Cardiovascular side effects of anabolic-androgenic steroids. Herz 2006; 31 (6): 566-573.
6. Zaugg M, Jamali NZ, Lucchinetti E, et al. Anabolic-androgenic steroids induce apoptotic cell death in adult rat ventricular myocytes. J Cell Physiol 2001; 187: 90-95.
7. Papamitsou T, Barlagiannis D, Papaliagkas V, et al. Testosterone-induced hypertrophy, fibrosis and apoptosis of cardiac cells-an ultrastructural and immunohistochemical study. Med Sci Monit 2011; 17: 266-273.
8. Lopes RA, Neves KB, Pestana CR, et al. Testosterone induces apoptosis in vascular smooth muscle cells via extrinsic apoptotic pathway with mitochondria-generated reactive oxygen species involvement. Am J Physiol Heart Circ Physiol 2014; 306 (11): H1485-H1494.
9. Hirota H, Chen J, Betz UA, et al. Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress. Cell 1999; 97: 189-198.
10. Vasconsuelo A, Pronsato L, Ronda AC, et al. Role of 17β-estradiol and testosterone in apoptosis. Steroids 2011; 76: 1223-1231.
11. Kang N, Fu L, Xu J, et al. Testosterone improves cardiac function and alters angiotensin II receptors in isoproterenol-induced heart failure. Arch Cardiovasc Dis 2012; 105: 68-76.
12. Schmitz I, Kirchhoff S, Krammer PH,. Regulation of death receptor mediated apoptosis pathways. Int J Biochem Cell Biol 2000; 32: 1123-1136.
13. Yamada T, Akishita M, Pollman MJ, et al. Angiotensin II type 2 receptor mediates vascular smooth muscle cell apoptosis and antagonizes angiotensin II type 1 receptor action: an in vitro gene transfer study. Life Sci 1998; 63 (19): PL289-PL295.
14. Igney FH, Krammer PH,. Death and anti-death: tumour resistance to apoptosis. Nat Rev Cancer 2002; 2 (4): 277-288.
15. Buemi M, Corica F, Marino D, et al. Cardiovascular remodeling, apoptosis, and drugs. Am J Hypertens 2000; 13 (4 Pt 1): 450-454.
16. Ehlers MR, Fox EA, Strydom DJ, et al. Molecular cloning of human testicular angiotensin-converting enzyme: the testis isozyme is identical to the C-terminal half of endothelial angiotensin-converting enzyme. Proc Natl Acad Sci USA 1989; 86 (20): 7741-7745.
17. Freshour JR, Chase SE, Vikstrom KL,. Gender differences in cardiac ACE expression are normalized in androgen-deprived male mice. Am J Physiol Hearth Circ Physiol 2002; 283: 1997-2003.
18. Liu Q, Wang G, Zhou G, et al. Angiotensin II-induced p53-dependent cardiac apoptotic cell death: its prevention by metallothionein. Toxicol Lett 2009; 191: 314-320.
19. Franquni JV, do Nascimento AM, de Lima EM, et al. Nandrolone decanoate determines cardiac remodeling and injury by an imbalance in cardiac inflammatory cytokines and ACE activity, blunting of the Bezold-Jarisch reflex, resulting in the development of hypertension. Steroids 2013; 78 (3): 379-385.
20. Andrade TU, Loiola LZ, Alcure SM, et al. Role of the renin-angiotensin system in the nandrolone-decanoate-induced attenuation of the Bezold-Jarisch reflex. Can J Physiol Pharmacol 2011; 89: 891-897.
21. Wan W, Jiang X, Li X, et al. Silencing of angiotensin converting enzyme by RNA interference prevents H9c2 cardiomyocytes from apoptosis induced by anoxia/reoxygenation through regulation of the intracellular renin-angiotensin system. Int J Mol Med 2013; 32 (6): 1380-1386.
22. Metcalfe PD, Leslie JA, Campbell MT, et al. Testosterone exacerbates obstructive renal injury by stimulating TNF production and increasing proapoptotic and profibrotic signaling. Am J Physiol Endocrinol Metab 2008; 294: 435-443.
23. Wang M, Gu H, Brewster BD, et al. Role of endogenous testosterone in TNF-induced myocardial injury in males. Int J Clin Exp Med 2012; 5: 96-104.
24. Zheng J, Liu Q, Yang J, et al. Co-culture of apoptotic breast cancer cells with immature dendritic cells: a novel approach for DC-based vaccination in breast cancer. Braz J Med Biol Res 2012; 45: 510-515.
25. Egberts J, Cloosters V, Noack A, et al. Anti-tumor necrosis factor therapy inhibits pancreatic tumor growth and metastasis. Canc Res 2008; 68: 1443-1450.
26. Pierzchalski P, Reiss K, Cheng W, et al. p53 induces myocyte apoptosis via the activation of the renin-angiotensin system. Exp Cell Res 1997; 234: 57-65.
27. Nicholson DW, Ali A, Thornberry NA, et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 1995; 376: 37-43.
28. Mosmann T,. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 365: 55-63.
29. Tada H, Kagaya Y, Takeda M, et al. Endogenous erythropoietin system in non-hematopoietic lineage cells plays a protective role in myocardial ischemia/reperfusion. Cardiovasc Res 2006; 71: 466-477.
30. Henriques T, Zhang X, Yiannikouris FB, et al. Androgen increases AT1a receptor expression in abdominal aortas to promote angiotensin II-induced AAAs in apolipoprotein E deficient mice. Arterioscler Thromb Vasc Biol 2008; 28: 1251-1256.
31. Do Carmo EC, Fernandes T, Koike D, et al. Anabolic steroid associated to physical training induces deleterious cardiac effects. Med Sci Sports Exerc 2011; 43: 1836-1848.
32. Rocha FL, Carmo EC, Roque FR, et al. Anabolic steroids induce cardiac renin-angiotensin system and impair the beneficial effects of aerobic training in rats. Am J Physiol Heart Circ Physiol 2007; 293: 3575-3583.
33. 2 receptors. J Hypertension 2001; 19: 1681-1689.
34. Abadir PM, Carey RM, Siragy HM,. Angiotensin AT2 receptors directly stimulate renal nitric oxide in bradykinin B2-receptor-null mice. Hypertension 2003; 42: 600-604.
35. Carey RM, Howell NL, Jin XH, et al. Angiotensin type-2 receptor-mediated hypotension in angiotensin type-1 receptor-blocked rats. Hypertension 2001; 38: 1272-1277.
36. Hunley TE, Tamura M, Stoneking BJ, et al. The angiotensin type II receptor tonically inhibits angiotensin-converting enzyme in AT2 null mutant mice. Kidney Inter 2000; 57: 570-577.
37. Gokce G, Karboga H, Yildiz E, et al. Effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on apoptotic changes in contralateral testis following unilateral testicular torsion. Int Urol Nephrol 2008; 40 (4): 989-995.
38. Du Toit EF, Rossouw E, Van Rooyen J, et al. Proposed mechanisms for the anabolic steroid-induced increase inmyocardial susceptibility to ischaemia/reperfusion injury. Cardiovasc J S Afr 2005; 16: 21-28.
39. Hughes TK, Fulep E, Juelich T, et al. Modulation of immune responses by anabolic androgenic steroids. Int J Immunopharmacol 1995; 17: 857-863.
40. Riezzo I, De Carlo D, Neri M, et al. Heart disease induced by AAS abuse, using experimental mice/rats models and the role of exercise-induced cardiotoxicity. Mini Rev Med Chem 2011; 11: 409-424.
41. Leri A, Liu Y, Li B, et al. Up-regulation of AT1 and AT2 receptors in postinfarcted hypertrophied myocytes and stretch-mediated apoptotic cell death. Am J Pathol 2000; 156: 1663-1672.
42. Reed JC,. Apoptosis-targeted therapies for cancer. Cancer Cell 2003; 3: 17-22.
43. Chai W, Zhang W, Jin Z, et al. Angiotensin II type I receptor agonistic autoantibody-induced apoptosis in neonatal rat cardiomyocytes is dependent on the generation of tumor necrosis factor-α. Acta Biochim Biophys Sin 2012; 44: 984-990.
44. Kalra D, Sivasubramanian N, Mann DL,. Angiotensin II induces tumor necrosis factor biosynthesis in the adult mammalian heart through a protein kinase C-dependent pathway. Circulation 2002; 105: 2198-2205.
45. Guarantz D, Cowling RT, Villarreal FJ, et al. Tumor necrosis factor-alpha upregulates angiotensin II type 1 receptors on cardiac fibroblasts. Circ Res 1999; 85: 272-279.